Skip to content

Clinical trials

Phase 2/3 trials in India

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2/3 Country / region: India Clear all

192 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20035
20042
20054
20068
200711
20089
20099
20106
20117
20128
20137
20148
201512
201613
201712
20186
20196
202010
20217
20229
20236
202410
202511
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed111
Unknown status27
Recruiting19
Terminated16
Active, not recruiting8
Withdrawn5
Not yet recruiting5
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Post Graduate Institute of Medical Education and Research, Chandigarh28
All India Institute of Medical Sciences18
Government Dental College and Research Institute, Bangalore13
Pfizer9
Bristol-Myers Squibb7
Lady Hardinge Medical College7
AstraZeneca4
Institute of Liver and Biliary Sciences, India4
Janssen Research & Development, LLC4
Tata Memorial Hospital4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 210
Aspergillosis, Allergic Bronchopulmonary7
COVID-197
Chronic Periodontitis7
Spasms, Infantile7
Fibrosis5
Liver Cirrhosis5
Carcinoma, Hepatocellular4
Crohn Disease4
Gallbladder Neoplasms4

Trials

Showing 1 to 25 of 192. Each trial links to its page on Pharma Observatory.

92 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.